WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Regulation FD Disclosure
Item 7.01Regulation FD Disclosure.

On May 3, 2018, West Pharmaceutical Services, Inc. (the “Company”) issued a press release announcing that its Board of Directors (the “Board”) has approved a third-quarter 2018 dividend of $0.14 per share. The dividend will be paid on August 1, 2018, to shareholders of record as of July 18, 2018.

In addition, the Company announced that its Board has approved a fourth-quarter dividend of $0.15 per share. The dividend will be paid on November 7, 2018, to shareholders of record as of October 24, 2018.

The Company also announced that management will present an overview of the business at the following investor conferences:

•Bank of America Merrill Lynch Healthcare Conference in Las Vegas, Nevada at 4:20 p.m. PDT on Tuesday, May

15, 2018; and

•UBS Global Healthcare Conference in New York, New York at 1:00 p.m. EDT on Monday, May 21, 2018.

A copy of the press release issued by the Company is attached hereto as Exhibit 99.1 and incorporated herein by reference.

A copy of the Company’s presentation materials from the conferences will be available through the Investors link at the

Company’s website, http://www.westpharma.com.

The information in this report (including Exhibit 99.1) is being furnished to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.

Item 9.01Financial Statements and Exhibits.

WEST PHARMACEUTICAL SERVICES INC Exhibit
EX-99.1 2 exh991may32018pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1Investor Contact:Media Contact:Quintin LaiEmily DenneyVice President,…
To view the full exhibit click here

About WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST)

West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions.